Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Sen. Durbin urges AMA, others to take action on opioid prescriptions

Durbin spoke with HealthExec about what he’s heard from physicians prescribing opioids, where he feels medical associations have fallen short, and whether federal legislation on prescribing practices will be needed.

Biden pushes for hospitals, providers, scientists to provide access to open data

Vice President Joe Biden spoke at Health Datapalooza in Washington, D.C. this week, emphasizing that his “moonshot” of curing cancer is “a matter of life and death.” 

House passed three bills in the fight against opioids

The House has passed three bills aimed at reducing opioid addiction in an overwhelming 410-1 vote, reports The Hill.

U of C’s $269M hospital expansion, trauma center approved despite criticism of cost

The plan had been criticized in an April by the Illinois Health Facilities and Services Review Board, which said the projected cost was about $18 million too high.

CMS seeks insurers to share ACA successes for June forum

Insurers finding success on the Affordable Care Act’s insurance exchanges are being asked to share what they’ve learned at a June CMS forum.

Will erasing state lines improve healthcare insurance?

The first in a series of videos from the Kaiser Health Network looks at the proposal to allow sales of policies across state lines.

Cybersecurity experts conduct hacker test on medical devices

Cybersecurity experts tested the vulnerability of software and medical devices at a group of hospitals, and they found hacking into the healthcare system is a lot easier than expected, reports WUSA9.    

Missouri governor vetoes $500K bill for HIT

Gov. Jay Nixon has vetoed a $500,000 bill that would’ve gone to a health information exchange program because he believes it would have favored one vendor over another.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.